Abstract
A drug for treating melanoma is ineffective in colorectal cancers that have the same causative mutation. Studies of how cells adapt to the drug reveal why this is so, and suggest combination therapies that may be more effective.
Cite
CITATION STYLE
APA
Solit, D. B., & Jänne, P. A. (2012). Primed for resistance. Nature, 483(7387), 44–45. https://doi.org/10.1038/483044a
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free